2024-04-012024-12-312024-12-31false12426667OPENORIGINS LIMITED2025-09-02falseiso4217:GBPxbrli:pure124266672024-03-31124266672024-12-31124266672024-04-012024-12-31124266672023-03-31124266672024-03-31124266672023-04-012024-03-3112426667bus:SmallEntities2024-04-012024-12-3112426667bus:AuditExempt-NoAccountantsReport2024-04-012024-12-3112426667bus:AbridgedAccounts2024-04-012024-12-3112426667bus:PrivateLimitedCompanyLtd2024-04-012024-12-3112426667core:WithinOneYear2024-12-3112426667core:AfterOneYear2024-12-3112426667core:WithinOneYear2024-03-3112426667core:AfterOneYear2024-03-3112426667core:ShareCapital2024-12-3112426667core:SharePremium2024-12-3112426667core:RevaluationReserve2024-12-3112426667core:OtherReservesSubtotal2024-12-3112426667core:RetainedEarningsAccumulatedLosses2024-12-3112426667core:ShareCapital2024-03-3112426667core:SharePremium2024-03-3112426667core:RevaluationReserve2024-03-3112426667core:OtherReservesSubtotal2024-03-3112426667core:RetainedEarningsAccumulatedLosses2024-03-3112426667core:LandBuildings2024-12-3112426667core:PlantMachinery2024-12-3112426667core:Vehicles2024-12-3112426667core:FurnitureFittings2024-12-3112426667core:OfficeEquipment2024-12-3112426667core:NetGoodwill2024-12-3112426667core:IntangibleAssetsOtherThanGoodwill2024-12-3112426667core:ListedExchangeTraded2024-12-3112426667core:UnlistedNon-exchangeTraded2024-12-3112426667core:LandBuildings2024-03-3112426667core:PlantMachinery2024-03-3112426667core:Vehicles2024-03-3112426667core:FurnitureFittings2024-03-3112426667core:OfficeEquipment2024-03-3112426667core:NetGoodwill2024-03-3112426667core:IntangibleAssetsOtherThanGoodwill2024-03-3112426667core:ListedExchangeTraded2024-03-3112426667core:UnlistedNon-exchangeTraded2024-03-3112426667core:LandBuildings2024-04-012024-12-3112426667core:PlantMachinery2024-04-012024-12-3112426667core:Vehicles2024-04-012024-12-3112426667core:FurnitureFittings2024-04-012024-12-3112426667core:OfficeEquipment2024-04-012024-12-3112426667core:NetGoodwill2024-04-012024-12-3112426667core:IntangibleAssetsOtherThanGoodwill2024-04-012024-12-3112426667core:ListedExchangeTraded2024-04-012024-12-3112426667core:UnlistedNon-exchangeTraded2024-04-012024-12-3112426667core:MoreThanFiveYears2024-04-012024-12-3112426667core:Non-currentFinancialInstruments2024-12-3112426667core:Non-currentFinancialInstruments2024-03-3112426667dpl:CostSales2024-04-012024-12-3112426667dpl:DistributionCosts2024-04-012024-12-3112426667core:LandBuildings2024-04-012024-12-3112426667core:PlantMachinery2024-04-012024-12-3112426667core:Vehicles2024-04-012024-12-3112426667core:FurnitureFittings2024-04-012024-12-3112426667core:OfficeEquipment2024-04-012024-12-3112426667dpl:AdministrativeExpenses2024-04-012024-12-3112426667core:NetGoodwill2024-04-012024-12-3112426667core:IntangibleAssetsOtherThanGoodwill2024-04-012024-12-3112426667dpl:GroupUndertakings2024-04-012024-12-3112426667dpl:ParticipatingInterests2024-04-012024-12-3112426667dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012024-12-3112426667core:ListedExchangeTraded2024-04-012024-12-3112426667dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012024-12-3112426667core:UnlistedNon-exchangeTraded2024-04-012024-12-3112426667dpl:CostSales2023-04-012024-03-3112426667dpl:DistributionCosts2023-04-012024-03-3112426667core:LandBuildings2023-04-012024-03-3112426667core:PlantMachinery2023-04-012024-03-3112426667core:Vehicles2023-04-012024-03-3112426667core:FurnitureFittings2023-04-012024-03-3112426667core:OfficeEquipment2023-04-012024-03-3112426667dpl:AdministrativeExpenses2023-04-012024-03-3112426667core:NetGoodwill2023-04-012024-03-3112426667core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112426667dpl:GroupUndertakings2023-04-012024-03-3112426667dpl:ParticipatingInterests2023-04-012024-03-3112426667dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112426667core:ListedExchangeTraded2023-04-012024-03-3112426667dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112426667core:UnlistedNon-exchangeTraded2023-04-012024-03-3112426667core:NetGoodwill2024-12-3112426667core:IntangibleAssetsOtherThanGoodwill2024-12-3112426667core:LandBuildings2024-12-3112426667core:PlantMachinery2024-12-3112426667core:Vehicles2024-12-3112426667core:FurnitureFittings2024-12-3112426667core:OfficeEquipment2024-12-3112426667core:AfterOneYear2024-12-3112426667core:WithinOneYear2024-12-3112426667core:ListedExchangeTraded2024-12-3112426667core:UnlistedNon-exchangeTraded2024-12-3112426667core:ShareCapital2024-12-3112426667core:SharePremium2024-12-3112426667core:RevaluationReserve2024-12-3112426667core:OtherReservesSubtotal2024-12-3112426667core:RetainedEarningsAccumulatedLosses2024-12-3112426667core:NetGoodwill2024-03-3112426667core:IntangibleAssetsOtherThanGoodwill2024-03-3112426667core:LandBuildings2024-03-3112426667core:PlantMachinery2024-03-3112426667core:Vehicles2024-03-3112426667core:FurnitureFittings2024-03-3112426667core:OfficeEquipment2024-03-3112426667core:AfterOneYear2024-03-3112426667core:WithinOneYear2024-03-3112426667core:ListedExchangeTraded2024-03-3112426667core:UnlistedNon-exchangeTraded2024-03-3112426667core:ShareCapital2024-03-3112426667core:SharePremium2024-03-3112426667core:RevaluationReserve2024-03-3112426667core:OtherReservesSubtotal2024-03-3112426667core:RetainedEarningsAccumulatedLosses2024-03-3112426667core:NetGoodwill2023-03-3112426667core:IntangibleAssetsOtherThanGoodwill2023-03-3112426667core:LandBuildings2023-03-3112426667core:PlantMachinery2023-03-3112426667core:Vehicles2023-03-3112426667core:FurnitureFittings2023-03-3112426667core:OfficeEquipment2023-03-3112426667core:AfterOneYear2023-03-3112426667core:WithinOneYear2023-03-3112426667core:ListedExchangeTraded2023-03-3112426667core:UnlistedNon-exchangeTraded2023-03-3112426667core:ShareCapital2023-03-3112426667core:SharePremium2023-03-3112426667core:RevaluationReserve2023-03-3112426667core:OtherReservesSubtotal2023-03-3112426667core:RetainedEarningsAccumulatedLosses2023-03-3112426667core:AfterOneYear2024-04-012024-12-3112426667core:WithinOneYear2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012024-12-3112426667core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3112426667core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3112426667core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112426667core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112426667core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112426667bus:Director12024-04-012024-12-3112426667bus:Director22024-04-012024-12-3112426667bus:Director32024-04-012024-12-31124266671bus:Director12024-03-31124266671bus:Director12024-04-012024-12-31124266671bus:Director12024-12-31124266672024-03-31124266672024-04-012024-12-31124266672024-12-31

OPENORIGINS LIMITED

Registered Number
12426667
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

OPENORIGINS LIMITED
Company Information
for the period from 1 April 2024 to 31 December 2024

Directors

AHMED, M A, Dr
BROWN, J
MITTAL, S B

Registered Address

53/54 3rd Floor
Grosvenor Street
London
W1K 3HU

Registered Number

12426667 (England and Wales)
OPENORIGINS LIMITED
Balance Sheet as at
31 December 2024

Notes

31 Dec 2024

31 Mar 2024

£

£

£

£

Fixed assets
Intangible assets315,78314,230
Tangible assets411,1049,550
26,88723,780
Current assets
Debtors5131,366122,854
Cash at bank and on hand3,208,401465,588
3,339,767588,442
Creditors amounts falling due within one year6(40,186)(19,105)
Net current assets (liabilities)3,299,581569,337
Total assets less current liabilities3,326,468593,117
Net assets3,326,468593,117
Capital and reserves
Called up share capital97
Share premium5,735,8412,252,020
Other reserves799-
Profit and loss account(2,410,181)(1,658,910)
Shareholders' funds3,326,468593,117
The financial statements were approved and authorised for issue by the Board of Directors on 2 September 2025, and are signed on its behalf by:
AHMED, M A, Dr
Director
BROWN, J
Director
MITTAL, S B
Director

Registered Company No. 12426667
OPENORIGINS LIMITED
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for at least 12 months from the date of approval of the financial statements. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from consultancy services provided in relation to the implementation or customization of the platform is recognized when the service is rendered. This includes any work done to integrate the platform with a customer’s existing systems or to provide training. Any revenue earned from the sale of data, reports, or additional features such as deepfake detection algorithms is recognized when the relevant deliverables are provided to the customer.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and any accumulated impairment losses. Amortisation is charged so as to allocate the cost of assets less their residual values over their estimated useful lives, using the straight-line method. Amortisation is charged at the following rate: Trademarks and patents - 25% Reducing Balance
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows: Computer Equipment - 25% Reducing Balance Fixtures & Fittings - 25% Reducing Balance
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees
including directors and key management personnel

20242024
Average number of employees during the year67
3.Intangible assets

Total

£
Cost or valuation
At 01 April 2421,035
Additions4,730
At 31 December 2425,765
Amortisation and impairment
At 01 April 246,805
Charge for year3,177
At 31 December 249,981
Net book value
At 31 December 2415,783
At 31 March 2414,230
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 2420,105
Additions3,765
At 31 December 2423,870
Depreciation and impairment
At 01 April 2410,555
Charge for year2,211
At 31 December 2412,766
Net book value
At 31 December 2411,104
At 31 March 249,550
5.Debtors: amounts due within one year

2024

2024

££
Trade debtors / trade receivables-84,000
Other debtors131,36638,854
Total131,366122,854
6.Creditors: amounts due within one year

2024

2024

££
Trade creditors / trade payables-3,406
Taxation and social security35,120-
Other creditors1,81610,949
Accrued liabilities and deferred income3,2504,750
Total40,18619,105
7.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
AHMED, M A, Dr1,228001,228
1,228001,228